Actipulse Neuroscience
New accelerator entry · 2022-01-25 · the record
In their words
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.
What the record says
- One of 44 companies held here in Healthcare › Medical Devices.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Actipulse Neuroscience
- Source Check — verify what Actipulse Neuroscience states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Actipulse Neuroscience for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Actipulse NeuroscienceYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Actipulse Neuroscience: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.